Evaluation of a Novel Graft-Holding Solution in Hair Transplantation: A Randomized Controlled Clinical Study

    April 2023 in “ Dermatologic surgery ”
    Yi Zhou, Jiaxian Zhang, Zhexiang Fan, Zhiqi Hu, Yong Miao
    Image of study
    TLDR The new graft-holding solution is better at preserving hair grafts and reducing hair shedding after transplantation than the standard solution.
    A randomized controlled clinical study involving 240 patients evaluated the impact of a novel graft-holding solution, histidine-tryptophan-ketoglutarate with adenosine triphosphate and deferoxamine (HTK-AD), on postsurgical hair shedding in hair transplantation. The study found that grafts preserved in HTK-AD maintained organized dense collagen construction and higher cell viability, while those in Ringer solution (RS) became soft, hindering implantation. HTK-AD significantly reduced the incidence of postsurgical hair shedding (73.81% vs 95%), delayed shedding onset, and diminished shedding amount when ≥3,000 grafts were transplanted. It also shortened the shedding duration and initiated hair regrowth earlier than RS, thus increasing patient satisfaction. However, the final survival rate of the grafts showed no difference between the two solutions. The study concluded that HTK-AD is superior to RS for hair graft preservation as it improves graft viability and alleviates postsurgical shedding.
    Discuss this study in the Community →

    Research cited in this study

    14 / 14 results

    Related Community Posts Join

    6 / 542 results

      community This is the best time in human history to be fighting hair loss

      in Treatment  193 upvotes 2 years ago
      This conversation discusses the advancements in treatments for hair loss, including finasteride, dutasteride, minoxidil and new promising treatments such as pyrilutamide and verteporfin. Other treatments discussed were taking minoxidil orally, tretinoin to turn non-responders into responders and microneedling to further boost growth.

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  449 upvotes 2 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

      community 17 month update 30M FUT 2300 grafts 1 year fin/min topical

      in Progress Pictures  414 upvotes 9 months ago
      A user shared a 17-month update on their hair loss treatment, which included a hair transplant of 2300 grafts, using a topical solution of minoxidil and finasteride, a laser cap, and ketoconazole shampoo. They are considering another transplant and seeking honest feedback on their progress, while others share their own experiences and advice on hair loss treatments.

    Similar Research

    5 / 1000+ results